SUXAMETHONIUM INTAS, SUXAMETHONIUM ACCORD (Accord Healthcare Pty Ltd)
Product name
SUXAMETHONIUM INTAS, SUXAMETHONIUM ACCORD
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
162 (255 working days)
Active ingredients
suxamethonium chloride dihydrate
Registration type
New generic medicine
Indication
SUXAMETHONIUM INTAS, SUXAMETHONIUM ACCORD (solution for injection, pre-filled) is indicated for the production of skeletal muscle relaxation in anaesthesia. Suited for procedures requiring only brief relaxation such as endotracheal intubation, endoscopic examinations, orthopaedic manipulations, short surgical procedures and electro-convulsive therapy.
Registration process
First generic
First approval of a medicine that contains the same active ingredient as and is bioequivalent to an existing medicine